Posttraumatic Stress Disorder and Inflammation: Untangling Issues of Bidirectionality

Biological Psychiatry

Volumn 87, Issue 10, 2020, Pages 885-897

  Sumner, Jennifer A ^a   Nishimi, Kristen M ^b   Koenen, Karestan C ^b   Roberts, Andrea L ^b   Kubzansky, Laura D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Bidirectionality; Inflammation; Inflammatory markers; Posttraumatic stress disorder; Trauma; Vulnerability

Indexed keywords

HUMAN; INFLAMMATION; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STATISTICAL ANALYSIS; LONGITUDINAL STUDY; RISK FACTOR;

HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85077713566     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2019.11.005     Document Type: Review

References (74)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Washington, DC.
2. Monson, C.M., Friedman, M.J., La Bash, H.A., A psychological history of PTSD. Friedman, M.J., Keane, T., Resick, P., (eds.) Handbook of PTSD: Science and Practice, 2007, Guilford Press, New York, NY, 37–52.
3. Koenen, K.C., Sumner, J.A., Gilsanz, P., Glymour, M.M., Ratanatharathorn, A., Rimm, E.B., et al. PTSD and cardiometabolic disease: Improving causal inference to inform practice. Psychol Med 47 (2017), 209–225.
4. Ryder, A.L., Azcarate, P.M., Cohen, B.E., PTSD and physical health. Curr Psychitry Rep, 20, 2018, 116.
5. Sumner, J.A., Kubzansky, L.D., Elkind, M.S., Roberts, A.L., Agnew-Blais, J.C., Chen, Q., et al. Trauma exposure and posttraumatic stress disorder symptoms predict onset of cardiovascular events in women. Circulation 132 (2015), 251–259.
6. Roberts, A.L., Agnew-Blais, J.C., Spiegelman, D., Kubzansky, L.D., Mason, S.M., Galea, S., et al. Posttraumatic stress disorder and incidence of type 2 diabetes mellitus in a sample of women: A 22-year longitudinal study. JAMA Psychiatry 72 (2015), 203–210.
7. O'Donovan, A., Cohen, B.E., Seal, K.H., Bertenthal, D., Margaretten, M., Nishimi, K., Neylan, T.C., Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry 77 (2015), 365–374.
8. Roberts, A.L., Malspeis, S., Kubzanksy, L.D., Feldman, C.H., Chang, S.C., Koenen, K.C., et al. Association of trauma and posttraumatic stress disorder with incident systemic lupus erythematosus in a longitudinal cohort of women. Arthritis Rheumatol 69 (2017), 2162–2169.
9. Sumner, J.A., Chen, Q., Roberts, A.L., Winning, A., Rimm, E.B., Gilsanz, P., et al. Posttraumatic stress disorder onset and inflammatory and endothelial function biomarkers in women. Brain Behav Immun 69 (2018), 203–209.
10. Eraly, S.A., Nievergelt, C.M., Maihofer, A.X., Barkauskas, D.A., Biswas, N., Agorastos, A., et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 71 (2014), 423–431.
11. Hori, H., Kim, Y., Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci 73 (2019), 143–153.
12. Michopoulos, V., Powers, A., Gillespie, C.F., Ressler, K.J., Jovanovic, T., Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 42 (2017), 254–270.
13. Inagaki, T.K., Muscatell, K.A., Irwin, M.R., Cole, S.W., Eisenberger, N.I., Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage 59 (2012), 3222–3226.
14. Irwin, M.R., Cole, S.W., Reciprocal regulation of the neural and innate immune systems. Nature Rev Immunol 11 (2011), 625–632.
15. Miller, A.H., Haroon, E., Raison, C.L., Felger, J.C., Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits. Depress Anxiety 30 (2013), 297–306.
16. Quan, N., Banks, W.A., Brain-immune communication pathways. Brain Behav Immun 21 (2007), 727–735.
17. Swartz, J.R., Prather, A.A., Di Iorio, C.R., Bogdan, R., Hariri, A.R., A functional interleukin-18 haplotype predicts depression and anxiety through increased threat-related amygdala reactivity in women but not men. Neuropsychopharmacology 42 (2017), 419–426.
18. Swartz, J.R., Prather, A.A., Hariri, A.R., Threat-related amygdala activity is associated with peripheral CRP concentrations in men but not women. Psychoneuroendocrinology 78 (2017), 93–96.
19. Yirmiya, R., Goshen, I., Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25 (2011), 181–213.
20. Bierhaus, A., Wolf, J., Andrassy, M., Rohleder, N., Humpert, P.M., Petrov, D., et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 100 (2003), 1920–1925.
21. Koenen, K.C., Hitsman, B., Lyons, M.J., Stroud, L., Niaura, R., McCaffery, J., et al. Posttraumatic stress disorder and late-onset smoking in the Vietnam era twin registry. J Consult Clin Psychol 74 (2006), 186–190.
22. Kubzansky, L.D., Bordelois, P., Jun, H.J., Roberts, A.L., Cerda, M., Bluestone, N., et al. The weight of traumatic stress: A prospective study of posttraumatic stress disorder symptoms and weight status in women. JAMA Psychiatry 71 (2014), 44–51.
23. Pitman, R.K., Rasmusson, A.M., Koenen, K.C., Shin, L.M., Orr, S.P., Gilbertson, M.W., et al. Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 13 (2012), 769–787.
24. Southwick, S.M., Bremner, J.D., Rasmusson, A., Morgan, C.A. III, Arnsten, A., Charney, D.S., Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46 (1999), 1192–1204.
25. Tan, K.S., Nackley, A.G., Satterfield, K., Maixner, W., Diatchenko, L., Flood, P.M., β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA-and NF-κB-independent mechanisms. Cell Signal 19 (2007), 251–260.
26. van den Berk-Clark, C., Secrest, S., Walls, J., Hallberg, E., Lustman, P.J., Schneider, F.D., et al. Association between posttraumatic stress disorder and lack of exercise, poor diet, obesity, and co-occuring smoking: A systematic review and meta-analysis. Health Psychol 37 (2018), 407–416.
27. Wingenfeld, K., Whooley, M.A., Neylan, T.C., Otte, C., Cohen, B.E., Effect of current and lifetime posttraumatic stress disorder on 24-h urinary catecholamines and cortisol: Results from the Mind Your Heart Study. Psychoneuroendocrinology 52 (2015), 83–91.
28. Winning, A., Gilsanz, P., Koenen, K.C., Roberts, A.L., Chen, Q., Sumner, J.A., et al. Post-traumatic stress disorder and 20-year physical activity trends among women. Am J Prev Med 52 (2017), 753–760.
29. Yehuda, R., Boisoneau, D., Lowy, M.T., Giller, E.L., Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 52 (1995), 583–593.
30. Yehuda, R., Lowy, M.T., Southwick, S., Shaffer, D., Giller, E.J., Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am J Psychiatry 148 (1991), 499–504.
31. Zen, A.L., Whooley, M.A., Zhao, S., Cohen, B.E., Post-traumatic stress disorder is associated with poor health behaviors: Findings from the heart and soul study. Health Psychol 31 (2012), 194–201.
32. Passos, I.C., Vasconcelos-Moreno, M.P., Costa, L.G., Kunz, M., Brietzke, E., Quevedo, J., et al. Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2 (2015), 1002–1012.
33. Breen, M.S., Maihofer, A.X., Glatt, S.J., Tylee, D.S., Chandler, S.D., Tsuang, M.T., et al. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol Psychiatry 20 (2015), 1538–1545.
34. Glatt, S.J., Tylee, D.S., Chandler, S.D., Pazol, J., Nievergelt, C.M., Woelk, C.H., et al. Blood-based gene-expression predictors of PTSD risk and resilience among deployed marines: A pilot study. Am J Med Genet B Neuropsychiatr Genet 162 (2013), 313–326.
35. van Zuiden, M., Heijnen, C.J., Maas, M., Amarouchi, K., Vermetten, E., Geuze, E., et al. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: A prospective study. Psychoneuroendocrinology 37 (2012), 1822–1836.
36. van Zuiden, M., Heijnen, C.J., van de Schoot, R., Amarouchi, K., Maas, M., Vermetten, E., et al. Cytokine production by leukocytes of military personnel with depressive symptoms after deployment to a combat-zone: A prospective, longitudinal study. PLoS One, 6, 2011, e29142.
37. Bielas, H., Meister-Langraf, R.E., Schmid, J.-P., Barth, J., Znoj, H., Schnyder, U., et al. C-reactive protein as a predictor of posttraumatic stress induced by acute myocardial infarction. Gen Hosp Psychiatry 53 (2018), 125–130.
38. Cohen, M., Meir, T., Klein, E., Volpin, G., Assaf, M., Pollack, S., Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents. Int J Psychiatry Med 42 (2011), 117–131.
39. Gandubert, C., Scali, J., Ancelin, M., Carriere, I., Dupuy, A.M., Bagnolini, G., et al. Biological and psychological predictors of posttraumatic stress disorder onset and chronicity: A one-year prospective study. Neurobiol Stress 3 (2016), 61–67.
40. Pervanidou, P., Kolaitis, G., Charitaki, S., Margeli, A., Ferentinos, S., Bakoula, C., et al. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 32 (2007), 991–999.
41. Segman, R., Shefi, N., Goltser-Dubner, T., Friedman, N., Kaminski, N., Shalev, A., Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry 10 (2005), 500–513.
42. Michopoulos, V., Beurel, E., Gould, F., Dhabhar, F.S., Schultebraucks, K., Galatzer-Levy, I., et al. Association of prospective risk for chronic PTSD symptoms with low TNFα and IFNγ concentrations in the immediate aftermath of trauma exposure. Am J Psychiatry 177 (2020), 58–65.
43. Glaus, J., von Känel, R., Lasserre, A.M., Strippoli, M.F., Vandeleur, C.L., Castelao, E., et al. The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based study. Depress Anxiety 35 (2018), 360–371.
44. Eswarappa, M., Neylan, T.C., Whooley, M.A., Metzler, T.J., Cohen, B.E., Inflammation as a predictor of disease course in posttraumatic stress disorder and depression: A prospective analysis from the Mind Your Heart Study. Brain Behav Immun 75 (2019), 220–227.
45. Smid, G.E., van Zuiden, M., Geuze, E., Kavelaars, A., Heijnen, C.J., Vermetten, E., Cytokine production as a putative biological mechanism underlying stress sensitization in high combat exposed soldiers. Psychoneuroendocrinology 51 (2015), 534–546.
46. Jergović, M., Bendelja, K., Savić Mlakar, A., Vojvoda, V., Aberle, N., Jovanovic, T., et al. Circulating levels of hormones, lipids, and immune mediators in post-traumatic stress disorder–a 3-month follow-up study. Front Psychiatry, 6, 2015, 49.
47. Solomon, Z., Levin, Y., Assayag, E.B., Furman, O., Shenhar-Tsarfaty, S., Berliner, S., et al. The implication of combat stress and PTSD trajectories in metabolic syndrome and elevated C-reactive protein levels: A longitudinal study. J Clin Psychiatry 78 (2017), e1180–e1186.
48. Sumner, J.A., Chen, Q., Roberts, A.L., Winning, A., Rimm, E.B., Gilsanz, P., et al. Cross-sectional and longitudinal associations of chronic posttraumatic stress disorder with inflammatory and endothelial function markers in women. Biol Psychiatry 82 (2017), 875–884.
49. Himmerich, H., Willmund, G.D., Zimmermann, P., Wolf, J.-E., Bühler, A.H., Kirkby, K.C., et al. Serum concentrations of TNF-a and its soluble receptors during psychotherapy in German soldiers suffering from combat-related PTSD. Psychiatr Danub 28 (2016), 293–298.
50. Tucker, P., Ruwe, W.D., Masters, B., Parker, D.E., Hossain, A., Trautman, R.P., et al. Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatry 56 (2004), 121–128.
51. Toft, H., Bramness, J.G., Lien, L., Abebe, D.S., Wampold, B.E., Tilden, T., et al. PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress. Neuropsychiatr Dis Treat 14 (2018), 2367–2378.
52. Davies, N.M., Holmes, M.V., Smith, G.D., Reading Mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ, 362, 2018, k601.
53. von Hinke, S., Smith, G.D., Lawlor, D.A., Propper, C., Windmeijer, F., Genetic markers as instrumental variables. J Health Econ 45 (2016), 131–148.
54. Zheng, J., Baird, D., Borges, M.-C., Bowden, J., Hemani, G., Haycock, P., et al. Recent developments in Mendelian randomization studies. Curr Epidemiol Rep 4 (2017), 330–345.
55. Sullivan, P.F., The psychiatric GWAS consortium: Big science comes to psychiatry. Neuron 68 (2010), 182–186.
56. Cornelis, M.C., Agrawal, A., Cole, J.W., Hansel, N.N., Barnes, K.C., Beaty, T.H., et al. The Gene, Environment Association Studies consortium (GENEVA): Maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiology 34 (2010), 364–372.
57. Nievergelt, C.M., Maihofer, A.X., Klengel, T., Atkinson, E.G., Chen, C.-Y., Choi, K.W., et al. Largest genome-wide association study for PTSD identifies genetic risk loci in European and African ancestries and implicates novel biological pathways. Nat Commun, 10, 2019, 4558.
58. Ligthart, S., Vaez, A., Võsa, U., Stathopoulou, M.G., De Vries, P.S., Prins, B.P., et al. Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders. Am J Hum Genet 103 (2018), 691–706.
59. Huang, M., Su, S., Goldberg, J., Miller, A.H., Levantsevych, O.M., Shallenberger, L., et al. Longitudinal association of inflammation with depressive symptoms: A 7-year cross-lagged twin difference study. Brain Behav Immun 75 (2019), 200–207.
60. Köhler, O., Benros, M.E., Nordentoft, M., Farkouh, M.E., Iyengar, R.L., Mors, O., et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: A systematic review and meta-analysis of randomized clinical trials. JAMA Psychiatry 71 (2014), 1381–1391.
61. Kappelmann, N., Lewis, G., Dantzer, R., Jones, P.B., Khandaker, G.M., Antidepressant activity of anti-cytokine treatment: A systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 23 (2018), 335–343.
62. Raison, C.L., Rutherford, R.E., Woolwine, B.J., Shuo, C., Schettler, P., Drake, D.F., et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: The role of baseline inflammatory biomarkers. JAMA Psychiatry 70 (2013), 31–41.
63. Dooley, L.N., Kuhlman, K.R., Robles, T.F., Eisenberger, N.I., Craske, M.G., Bower, J.E., The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. Neurosci Biobehav Rev 94 (2018), 219–237.
64. Nawijn, L., van Zuiden, M., Frijling, J.L., Koch, S.B., Veltman, D.J., Olff, M., Reward functioning in PTSD: A systematic review exploring the mechanisms underlying anhedonia. Neurosci Biobehav Rev 51 (2015), 189–204.
65. Bryant, R.A., Guthrie, R.M., Maladaptive appraisals as a risk factor for posttraumatic stress: A study of trainee firefighters. Psychol Sci 16 (2005), 749–752.
66. Pole, N., Neylan, T.C., Otte, C., Henn-Hasse, C., Metzler, T.J., Marmar, C.R., Prospective prediction of posttraumatic stress disorder symptoms using fear potentiated auditory startle responses. Biol Psychiatry 65 (2009), 235–240.
67. Tursich, M., Neufeld, R., Frewen, P., Harricharan, S., Kibler, J.L., Rhind, S.G., et al. Association of trauma exposure with proinflammatory activity: A transdiagnostic meta-analysis. Transl Psychiatry, 4, 2014, e413.
68. Renna, M.E., O'Toole, M.S., Spaeth, P.E., Lekander, M., Mennin, D.S., The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: A systematic review and meta-analysis. Depress Anxiety 35 (2018), 1081–1094.
69. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 67 (2010), 446–457.
70. Gibney, E., Nolan, C., Epigenetics and gene expression. Heredity 105 (2010), 4–13.
71. Blander, J.M., Longman, R.S., Iliev, I.D., Sonnenberg, G.F., Artis, D., Regulation of inflammation by microbiota interactions with the host. Nat Immunol 18 (2017), 851–860.
72. Hemmings, S.M., Malan-Muller, S., van den Heuvel, L.L., Demmitt, B.A., Stanislawski, M.A., Smith, D.G., et al. The microbiome in posttraumatic stress disorder and trauma-exposed controls: An exploratory study. Psychosom Med 79 (2017), 936–946.
73. Mellon, S.H., Bersani, F.S., Lindqvist, D., Hammamieh, R., Donohue, D., Dean, K., et al. Metabolomic analysis of male combat veterans with post traumatic stress disorder. PLoS One, 14, 2019, e0213839.
74. O'Donovan, A., Ahmadian, A.J., Neylan, T.C., Pacult, M.A., Edmondson, D., Cohen, B.E., Current posttraumatic stress disorder and exaggerated threat sensitivity associated with elevated inflammation in the Mind Your Heart Study. Brain Behav Immun 60 (2017), 198–205.